Stability of the Industrial Reference Standard of Tuberculosis Vaccine (BCG)
Н. В. Александрова(Onze Lieve Vrouwziekenhuis Hospital), Levi Dt(Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care"), A. A. Savina, A. V. Nakonechnaya
Biological Products Prevention Diagnosis Treatment
September 18, 2020
Cited by 0
Related Papers
Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
|Genome Announcements|2015|9
Sepsis in Latvia—Incidence, Outcomes, and Healthcare Utilization: A Retrospective, Observational Study
|Healthcare|2024|2
Specific Aspects of Tuberculin Products Standardisation
|Biological Products Prevention Diagnosis Treatment|2019|1
Using Shewhart charts to monitor quality characteristics of preventive vaccines for tuberculosis
|Biological Products Prevention Diagnosis Treatment|2023|1
A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient
|International Journal of Emergency Medicine|2024|1